Recombinant Human CD33 Protein (Met17-His259), C-hFc and Avi-tagged, Biotinylated
Product Description
Cat
IMP-10603
Official Symbol
CD33
Product Overview
Biotinylated recombinant human Siglec-3/CD33 protein (Met17-His259) with a Human IgG1 (Pro100-Lys330) Fc tag and Avi-tag at C-terminus was expressed in Human embryonic kidney cell.
Description
Enables protein phosphatase binding activity and sialic acid binding activity. Involved in several processes, including negative regulation of cytokine production; negative regulation of monocyte activation; and positive regulation of protein tyrosine phosphatase activity. Located in several cellular components, including Golgi apparatus; external side of plasma membrane; and peroxisome.
Expression System
HEK293
Species
Human
Tag
C-hFc and Avi
Predicted N Terminal
Met17
Form
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Conjugate
Biotinylated
Molecular Mass
Predicted Molecular Mass: 15 kDa
SDS-PAGE: 67-78 kDa, under reducing conditions
Protein length
Met17-His259
Bio-activity
Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. The ED50 for this effect is 0.2-1.4 μg/mL. Measured by its binding ability in a functional ELISA. When Human Siglec-3/CD33 (6C5/2) Antibody is immobilized at 0.5 μg/mL (100 μL/well), Biotinylated Recombinant Human Siglec-3/CD33 Fc Chimera binds with an ED50 of 0.15-1.2 ng/mL.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Notes
Disulfide-linked homodimer, biotinylated via Avi-tag
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 500 μg/mL in PBS.
SDS-PAGE
SDS-PAGE

Bioactivity-ELISA 1
Binding Activity

Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. The ED50 for this effect is 0.2-1.4 μg/mL. Measured by its binding ability in a functional ELISA. When Human Siglec-3/CD33 (6C5/2) Antibody is immobilized at 0.5 μg/mL (100 μL/well), Biotinylated Recombinant Human Siglec-3/CD33 Fc Chimera binds with an ED50 of 0.15-1.2 ng/mL.

Data Sheet MSDS
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry
Contact Info